Enhanced LH action in transgenic female mice expressing hCGβ-subunit induces pituitary prolactinomas; the role of high progesterone levels

Endocrine-Related Cancer

Volumn 17, Issue 3, 2010, Pages 611-621

  Ahtiainen, Petteri ^a   Sharp, Victoria ^b   Rulli, Susana B ^a,c   Rivero Müller, Adolfo ^a   Mamaeva, Veronika ^a   Röyttä, Matias ^a   Huhtaniemi, Ilpo ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CHORIONIC GONADOTROPIN BETA SUBUNIT; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; ESTRADIOL; LUTEINIZING HORMONE; MIFEPRISTONE; PROGESTERONE; RETINOBLASTOMA PROTEIN; TAMOXIFEN; TRANSCRIPTION FACTOR E2F1; PROLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; GONADECTOMY; HISTOLOGY; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARY; PROGESTERONE RELEASE; PROLACTINOMA; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TUMOR GROWTH; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; CELL PROLIFERATION; CYTOLOGY; GENETICS; HYPOPHYSIS; METABOLISM;

ANALYSIS OF VARIANCE; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CYCLIN-DEPENDENT KINASE 4; FEMALE; LUTEINIZING HORMONE; MICE; MICE, TRANSGENIC; PITUITARY GLAND; PITUITARY NEOPLASMS; PROGESTERONE; PROLACTIN; PROLACTINOMA; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77956224160     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-10-0016     Document Type: Article

References (42)

1. Ahtiainen P, Rulli SB, Shariatmadari R, Pelliniemi LJ, Toppari J, Poutanen M & Huhtaniemi IT 2005 Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level: a study on hCG overexpressing transgenic mice. Oncogene 24 7301-7309. (Pubitemid 41622234)
2. Bergendahl M, Perheentupa A & Huhtaniemi I 1989 Effect of short-term starvation on reproductive hormone gene expression, secretion and receptor levels in male rats. Journal of Endocrinology 121 409-417. (Pubitemid 19142453)
3. Chen CL & Meites J 1970 Effects of estrogen and progesterone on serum and pituitary prolactin levels in ovariectomized rats. Endocrinology 86 503-505.
4. Cicatiello L, Addeo R, Sasso A, Altucci L, Petrizzi VB, Borgo R, Cancemi M, Caporali S, Caristi S, Scafoglio C et al. 2004 Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Molecular and Cellular Biology 24 7260-7274.
5. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA & Beckers A 2006 High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. Journal of Clinical Endocrinology and Metabolism 91 4769-4775. (Pubitemid 44917305)
6. Drange MR, Fram NR, Herman-Bonert V & Melmed S 2000 Pituitary tumor registry: a novel clinical resource. Journal of Clinical Endocrinology and Metabolism 85 168-174. (Pubitemid 32268809)
7. Eigeliene N, Harkonen P & Erkkola R 2008 Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues. Cell Cycle 7 71-80.
8. Faglia G 1993 Epidemiology and pathogenesis of pituitary adenomas. Acta Endocrinologica 129 1-5.
9. Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S, Ciarmiello A, Pallante P, Arra C, Melillo RM et al. 2006 HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9 459-471.
10. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L & Xiong Y 1998 CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes and Development 12 2899-2911. (Pubitemid 28440148)
11. Haug E & Gautvik KM 1976 Effects of sex steroids on prolactin secreting rat pituitary cells in culture. Endocrinology 99 1482-1489. (Pubitemid 8003981)
12. Heaney AP, Fernando M & Melmed S 2002 Functional role of estrogen in pituitary tumor pathogenesis. Journal of Clinical Investigation 109 277-283. (Pubitemid 34083748)
13. Hentges ST & Low MJ 2002 Ovarian dependence for pituitary tumorigenesis in D2 dopamine receptor-deficient mice. Endocrinology 143 4536-4543.
14. Hyde JF, Engle MG & Maley BE 1991 Colocalization of galanin and prolactin within secretory granules of anterior pituitary cells in estrogen-treated Fischer 344 rats. Endocrinology 129 270-276.
15. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA & Weinberg RA 1992 Effects of an Rb mutation in the mouse. Nature 359 295-300.
16. Jaffrain-Rea ML, Petrangeli E, Ortolani F, Fraioli B, Lise A, Esposito V, Spagnoli LG, Tamburrano G, Frati L & Gulino A 1996 Cellular receptors for sex steroids in human pituitary adenomas. Journal of Endocrinology 151 175-184. (Pubitemid 26397995)
17. Kashima H, Shiozawa T, Miyamoto T, Suzuki A, Uchikawa J, Kurai M & Konishi I 2009 Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E. Endocrine-Related Cancer16 113-122.
18. Lamberts SW, Uitterlinden P, Bons EG & Verleun T 1985 Comparison of the actions of RU 38486 and megestrol acetate in the model of a transplantable adrenocorticotropin- and prolactin-secreting rat pituitary tumor. Cancer Research 45 1015-1019. (Pubitemid 15111253)
19. Lavoie JN, L'Allemain G, Brunet A, Muller R & Pouyssegur J 1996 Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. Journal of Biological Chemistry 271 20608-20616. (Pubitemid 26281839)
20. Lieberman ME, Maurer RA, Claude P, Wiklund J, Wertz N & Gorski J 1981 Regulation of pituitary growth and prolactin gene expression by estrogen. Advances in Experimental Medicine and Biology 138 151-163.
21. Liu JC, Baker RE, Sun C, Sundmark VC & Elsholtz HP 2002 Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin gene. Journal of Biological Chemistry 277 35819-35825.
22. Martin L, Hallowes RC, Finn CA & West DG 1973 Involvement of the uterine blood vessels in the refractory state of the uterine stroma which follows oestrogen stimulation in progesterone-treated mice. Journal of Endocrinology 56 309-314.
23. Maurer RA 1982 Estradiol regulates the transcription of the prolactin gene. Journal of Biological Chemistry 257 2133-2136. (Pubitemid 12069761)
24. McComb DJ, Ryan N, Horvath E & Kovacs K 1983 Subclinical adenomas of the human pituitary. New light on old problems. Archives of Pathology & Laboratory Medicine 107 488-491.
25. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M & Auricchio F 1998 Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO Journal 17 2008-2018.
26. Molitch ME 1999 Management of prolactinomas during pregnancy. Journal of Reproductive Medicine 44 1121-1126.
27. Mueller A & Gooren L 2008 Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. European Journal of Endocrinology 159 197-202.
28. Musat M, Vax VV, Borboli N, Gueorguiev M, Bonner S, Korbonits M & Grossman AB 2004 Cell cycle dysregulation in pituitary oncogenesis. Frontiers of Hormone Research 32 34-62.
29. Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grubler Y, Chervin A, Goldberg V, Goya R, Hentges ST et al. 2003 Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. PNAS 100 1034-1039.
30. Pastorcic M, De A, Boyadjieva N, Vale W & Sarkar DK 1995 Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Cancer Research 55 4892-4898.
31. Peters G 1994 The D-type cyclins and their role in tumorigenesis. Journal of Cell Science. Supplement 18 89-96.
32. Piroli GG, Cassataro J, Pietranera L, Grillo CA, Ferrini M, Lux-Lantos V & De Nicola AF 2001 Progestin regulation of galanin and prolactin gene expression in oestrogen-induced pituitary tumours. Journal of Neuroendocrinology 13 302-309. (Pubitemid 32170996)
33. Poel WE 1966 Pituitary tumors in mice after prolonged feeding of synthetic progestins. Science 154 402-403.
34. Rey-Roldan EB, Grillo CA, Pietranera L, Libertun C, Nicola AF & Piroli GG 2008 Levonorgestrel antagonism on estrogen-induced pituitary tumors is mediated by progesterone receptors. Hormone and Metabolic Research 40 245-250. (Pubitemid 351533106)
35. Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M & Huhtaniemi I 2002 Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 143 4084-4095. (Pubitemid 35244387)
36. Saitoh M, Ohmichi M, Takahashi K, Kawagoe J, Ohta T, Doshida M, Takahashi T, Igarashi H, Mori-Abe A, Du B et al. 2005 Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells. Endocrinology 146 4917-4925.
37. Sutherland RL, Prall OW, Watts CK & Musgrove EA 1998 Estrogen and progestin regulation of cell cycle progression. Journal of Mammary Gland Biology and Neoplasia 3 63-72.
38. Turgeon JL, Shyamala G & Waring DW 2001 PR localization and anterior pituitary cell populations in vitro in ovariectomized wild-type and PR-knockout mice. Endocrinology 142 4479-4485.
39. Walker BE & Kurth LA 1993 Pituitary tumors in mice exposed prenatally to diethylstilbestrol. Cancer Research 53 1546-1549.
40. Williams RF, Gordon K, Fung H, Kolm P & Hodgen GD 1994 Hypothalamo-pituitary effects of RU486: inhibition of progesterone-induced hyperprolactinaemia. Human Reproduction 9 63-68. (Pubitemid 24203929)
41. Yamasaki L, Bronson R, Williams BO, Dyson NJ, Harlow E & Jacks T 1998 Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nature Genetics 18 360-364. (Pubitemid 28158165)
42. Yen SH & Pan JT 1998 Progesterone advances the diurnal rhythm of tuberoinfundibular dopaminergic neuronal activity and the prolactin surge in ovariectomized, estrogen-primed rats and in intact proestrous rats. Endocrinology 139 1602-1609.